ACT Brief: China’s Startup Timelines, AI-Drafted Clinical Study Reports, and Bimzelx Psoriatic Arthritis Data

0:00-1:47

In today’s ACT Brief, we examine how China’s trial startup timelines compare with those in the US and Europe, whether AI-drafted clinical study reports speed drug development, and how Bimzelx compared with Skyrizi in psoriatic arthritis.

Publisher

Applied Clinical Trials

Link

audioboom.com/posts/8975115

Published

November 10, 2026

Duration

2 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

AC

Applied Clinical Trials

@appliedclinicaltrials

#chinasstartuptimelines #draftedclinicalstudy #bimzelxpsoriaticarthritis #lifesciences

The Nile